Free Shipping Within the US
Money Back Guarantee


Dale blog imageAuthor: Dale Hewett
Table of Contents (Scrollable)

Delta-9-cis-tetrahydrocannabinol (cisTHC) is a synthetic cannabinoid. These compounds don’t occur naturally in the cannabis plant.

Synthetic compounds are often products of certain chemical functions or reactions between two cannabinoids and their environment.

The degradation of cannabinol (CBN) leads to the formation of other compounds, through conversion from their precursors. During the process of isolating a certain compound, other compounds may be derived.

Related: What is Delta 9 THC?

Cannabinol was discovered in 1940 by British scientist Robert Cahn. In 1986, a group of scientists under R.K. Razdan analyzed the structural-activity relationship (SAR) of cannabinoids. We don’t know who discovered the cis-THC compound, although the earliest mention of the compound was in 2017.

The formation of cis-THC is purely synthetic and doesn’t occur naturally in the cannabis plant. Although in name, cis-THC sounds similar to the THC compound derived from the CBN and cannabigerivarin (CGBV) mother compounds, they are not be mistaken for each other.

The compound cis-THC is said to have no similarity to the THC family hence its non-categorization and its miscellaneous compound tag. Rather, its structure similarity is with compounds like cannabrichromene, synhexyl, dibenzo(b,d)pyran-6-methanol, and some others.

In its chemical structure, cis-THC has an HBD count of 1, HBA of 2, and RB count of 4. With a topological surface area of 29.5A2, a heavy atom count of 23, its property complexity value is 439.

Owing to its small quantity and pervasive nature, cis-THC is one of the unique compounds of the marijuana plant. Without research and clinical trials, there is no knowing what this compound can do.

Related: How Long Does Delta 8 THC Stay In Your System?

The future of the compound is very much tied to the legal status of cannabis in the world. With the US leading the way in legalization, we are hoping that other countries will follow its lead by allowing the use of the compound and plant in the world of medicine.


Cannabinoids are known to bond with the human endocannabinoid receptors found throughout in the body.

Related: What is CBN?

These receptors are encoded with a protein like constituent and found to be tied to the body’s immune system and central nervous system. Cannabidiols combine with these receptors to perform their functions.

Cis-THC hasn’t gone through clinical trials and tests for us to know how it functions at these receptor points. To know more about how the compound works, we will have to wait until these trials, research, and experiments.


Cannabidiols are a promising category of compounds with many theorized therapeutic uses. We have observed some of these compounds to be psychoactive, while some that act as nerve blockers. Their practical uses are extensive, even helping things like diarrhea, insomnia, etc.

Related: CBD vs CBN

The cis-THC compound will doubtlessly have its own features and benefits for treating ailments and diseases; we just need the research and trials to begin in earnest.


  1. It has a molar mass of 314.5 g/mol.
  2. Its chemical formula is C21H30O2.
  3. Its IUPAC name is (6aS,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol.

Cbd Products For Sale


National Center for Biotechnology Information. PubChem Compound Summary for CID 12831993, delta-9-cis-Tetrahydrocannabinol, (-)-. 

Prandi C, Blangetti M, Namdar D, Koltai H. Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases. Molecules. 2018 Jun 25;23(7):1526. doi: 10.3390/molecules23071526. PMID: 29941830; PMCID: PMC6099582.

Uliss DB, Dalzell HC, Handrick GR, Howes JF, Razdan RK. Hashish. Importance of the phenolic hydroxyl group in tetrahydrocannabinols. J Med Chem. 1975 Feb;18(2):213-ss5. doi: 10.1021/jm00236a025. PMID: 1120991.

blog BG
Table of Contents

Search our website for more information on CBD:

Related Cannabinoids

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett Author
Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

la wire logo
yahoo finance greyscale
forbes logo
Markets Insider Logo
chicago journal logo greyscale